This observational study is looking at a new way to predict how patients with chronic lung disease and pulmonary hypertension (high blood pressure in the lungs) might fare over one year. Researchers are testing a tool called the PVD-B65 risk score, which uses information from standard medical tests. This score was developed to help understand the risk of death within one year for people with these conditions. The study will assign this score to patients and then follow them to see if it accurately predicts their health outcomes. You may be eligible if you are an adult between 18 and 99 years old, have chronic lung disease, and have been diagnosed with pre-capillary pulmonary hypertension through a right-heart catheterization.

Study design

This is an observational study with a planned enrollment of 100 participants. It is designed to see if a risk score can predict outcomes without any new treatments.

What's involved

Participants will have a PVD-B65 score assigned at the time of diagnosis or referral, based on standard medical tests. They will then be followed for one year to track their health outcomes.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for one year to assess mortality outcomes.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.